Edition:
United Kingdom

Zosano Pharma Corp (ZSAN.OQ)

ZSAN.OQ on NASDAQ Stock Exchange Capital Market

0.66USD
3:02pm GMT
Change (% chg)

$0.03 (+4.78%)
Prev Close
$0.63
Open
$0.62
Day's High
$0.67
Day's Low
$0.62
Volume
56,592
Avg. Vol
134,484
52-wk High
$3.53
52-wk Low
$0.56

Select another date:

Thu, Nov 9 2017

BRIEF-Zosano pharma Q3 loss per share $0.20

* Zosano pharma reports third quarter 2017 financial results and operational update

BRIEF-Zosano Pharma announces initiation of long-term safety study for M207

* Zosano Pharma announces initiation of long-term safety study for M207 as an acute treatment of migraine Source text for Eikon: Further company coverage:

BRIEF-Zosano enters into common stock purchase agreement with Lincoln Park Capital

* Zosano enters into common stock purchase agreement with Lincoln Park Capital Source text for Eikon: Further company coverage:

BRIEF-Zosano appoints Kenneth Greathouse to board of directors

* Zosano appoints Kenneth Greathouse to board of directors Source text for Eikon: Further company coverage:

BRIEF-Zosano provides patent application update

* Zosano Pharma Corp - Received official written notification of an office action from U.S. patent and trademark office

BRIEF-Zosano Pharma Q2 loss per share $0.17

* Zosano Pharma reports second quarter 2017 financial results and operational update

BRIEF-Zosano Pharma announces outcome of end of phase 2 meetings with FDA

* Zosano Pharma announces outcome of end of phase 2 meetings with FDA

Select another date: